Answers are grounded in this paper and cite their sources.
Background and Aims:The nuclear factor small heterodimer partner (SHP) plays a dual function in maintaining BA homeostasis and exerting anti-inflammatory effects.While SHP might be associated with metabolic dysfunction-associated steatohepatitis (MASH), its role in patients remains unclear. Methods: Liver tissue and serum samples were collected from 69 patients with MASH and 10 healthy controls.The subcellular distribution of SHP and related proteins in liver tissue were analyzed to correlate with MASH-associated pathological characteristics.In vitro studies were conducted to elucidate the underlying mechanisms and clinical relevance of SHP nuclear translocation in MASH.Results: Compared with controls, MASH patients demonstrated a higher nuclear SHP ratio (51.7% vs. 1.55%, p<0.001), which correlated with the severity of hepatitis and steatosis, but not with serum BA levels.The nuclear SHP ratio increased in parallel with atypical protein kinase C zeta (PKC) signal intensity and showed high co-localization with nucleoporin RanBP2.In vitro experiments demonstrated that both toxic fatty acid and inflammatory cytokine could induce SHP nuclear translocation, which was blocked by PKC inhibition.SHP knockdown escalated basal innate immune components, accelerated intracellular lipid accumulation, and recapitulated a MASH-like gene profile that facilitates BA accumulation.Conclusions: Nuclear SHP accumulation is a distinctive feature of MASH pathology.This PKC-dependent process may exert anti-inflammation and anti-cholestasis function in patients with MASH.
No takes yet. Share an insight, caveat, or question.
Chien et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: